These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16051735)

  • 1. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes.
    Rubio-Moscardo F; Blesa D; Mestre C; Siebert R; Balasas T; Benito A; Rosenwald A; Climent J; Martinez JI; Schilhabel M; Karran EL; Gesk S; Esteller M; deLeeuw R; Staudt LM; Fernandez-Luna JL; Pinkel D; Dyer MJ; Martinez-Climent JA
    Blood; 2005 Nov; 106(9):3214-22. PubMed ID: 16051735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma.
    Lee SH; Shin MS; Kim HS; Lee HK; Park WS; Kim SY; Lee JH; Han SY; Park JY; Oh RR; Kang CS; Kim KM; Jang JJ; Nam SW; Lee JY; Yoo NJ
    Oncogene; 2001 Jan; 20(3):399-403. PubMed ID: 11313970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8p21.3 deletion suggesting a probable role of TRAIL-R1 and TRAIL-R2 as candidate tumor suppressor genes in the pathogenesis of multiple myeloma.
    Gmidène A; Saad A; Avet-Loiseau H
    Med Oncol; 2013 Jun; 30(2):489. PubMed ID: 23423784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.
    Walczak H; Degli-Esposti MA; Johnson RS; Smolak PJ; Waugh JY; Boiani N; Timour MS; Gerhart MJ; Schooley KA; Smith CA; Goodwin RG; Rauch CT
    EMBO J; 1997 Sep; 16(17):5386-97. PubMed ID: 9311998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies.
    MacFarlane M; Kohlhaas SL; Sutcliffe MJ; Dyer MJ; Cohen GM
    Cancer Res; 2005 Dec; 65(24):11265-70. PubMed ID: 16357130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution of the death ligand TRAIL and its receptors.
    Spierings DC; de Vries EG; Vellenga E; van den Heuvel FA; Koornstra JJ; Wesseling J; Hollema H; de Jong S
    J Histochem Cytochem; 2004 Jun; 52(6):821-31. PubMed ID: 15150291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers.
    Shin MS; Kim HS; Lee SH; Park WS; Kim SY; Park JY; Lee JH; Lee SK; Lee SN; Jung SS; Han JY; Kim H; Lee JY; Yoo NJ
    Cancer Res; 2001 Jul; 61(13):4942-6. PubMed ID: 11431320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.
    Horak P; Pils D; Haller G; Pribill I; Roessler M; Tomek S; Horvat R; Zeillinger R; Zielinski C; Krainer M
    Mol Cancer Res; 2005 Jun; 3(6):335-43. PubMed ID: 15972852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.
    Kuijlen JM; Mooij JJ; Platteel I; Hoving EW; van der Graaf WT; Span MM; Hollema H; den Dunnen WF
    J Neurooncol; 2006 Jun; 78(2):161-71. PubMed ID: 16544055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers.
    Lee SH; Shin MS; Kim HS; Lee HK; Park WS; Kim SY; Lee JH; Han SY; Park JY; Oh RR; Jang JJ; Han JY; Lee JY; Yoo NJ
    Cancer Res; 1999 Nov; 59(22):5683-6. PubMed ID: 10582684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
    Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
    J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity.
    Adams J; Cuthbert-Heavens D; Bass S; Knowles MA
    Cancer Lett; 2005 Apr; 220(2):137-44. PubMed ID: 15766588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
    Perlman H; Nguyen N; Liu H; Eslick J; Esser S; Walsh K; Moore TL; Pope RM
    Arthritis Rheum; 2003 Nov; 48(11):3096-101. PubMed ID: 14613271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis and mRNA expression of trail-receptors in human breast cancer.
    Seitz S; Wassmuth P; Fischer J; Nothnagel A; Jandrig B; Schlag PM; Scherneck S
    Int J Cancer; 2002 Nov; 102(2):117-28. PubMed ID: 12385006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis-mediating receptor-ligand systems in human retinal pigment epithelial cells.
    Hueber A; Aduckathil S; Kociok N; Welsandt G; Dinslage S; Kirchhof B; Esser PJ
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):551-6. PubMed ID: 12136286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two receptors for TRAIL.
    Schneider P; Bodmer JL; Thome M; Hofmann K; Holler N; Tschopp J
    FEBS Lett; 1997 Oct; 416(3):329-34. PubMed ID: 9373179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of gene mutation in TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2) in chronic myelogenous leukemia and myelodysplastic syndrome, and analysis of mRNA Expressions of TRAIL and TRAIL-related genes in chronic myelogenous leukemia.
    Liu LG; Tanaka H; Ito K; Ito T; Sultana TA; Kyo T; Kimura A
    Acta Haematol; 2005; 113(2):113-23. PubMed ID: 15802890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation.
    Mühlenbeck F; Schneider P; Bodmer JL; Schwenzer R; Hauser A; Schubert G; Scheurich P; Moosmayer D; Tschopp J; Wajant H
    J Biol Chem; 2000 Oct; 275(41):32208-13. PubMed ID: 10807904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
    Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T
    Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells.
    Oshima K; Yanase N; Ibukiyama C; Yamashina A; Kayagaki N; Yagita H; Mizuguchi J
    Cytokine; 2001 May; 14(4):193-201. PubMed ID: 11448118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.